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Abstract
The highly prevalent parasite Toxoplasma gondii manipulates its host’s behavior. In infected rodents, the behavioral changes
increase the likelihood that the parasite will be transmitted back to its definitive cat host, an essential step in completion of
the parasite’s life cycle. The mechanism(s) responsible for behavioral changes in the host is unknown but two lines of
published evidence suggest that the parasite alters neurotransmitter signal transduction: the disruption of the parasite-
induced behavioral changes with medications used to treat psychiatric disease (specifically dopamine antagonists) and
identification of a tyrosine hydroxylase encoded in the parasite genome. In this study, infection of mammalian
dopaminergic cells with T. gondii enhanced the levels of K+-induced release of dopamine several-fold, with a direct
correlation between the number of infected cells and the quantity of dopamine released. Immunostaining brain sections of
infected mice with dopamine antibody showed intense staining of encysted parasites. Based on these analyses, T. gondii
orchestrates a significant increase in dopamine metabolism in neural cells. Tyrosine hydroxylase, the rate-limiting enzyme
for dopamine synthesis, was also found in intracellular tissue cysts in brain tissue with antibodies specific for the parasite-
encoded tyrosine hydroxylase. These observations provide a mechanism for parasite-induced behavioral changes. The
observed effects on dopamine metabolism could also be relevant in interpreting reports of psychobehavioral changes in
toxoplasmosis-infected humans.
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Introduction
A complex range of interactions exist between a pathogen with
its host, which may include manipulation of the host for the
pathogen’s own advantage. There are several examples of viruses,
such as rabies virus [1], and parasites, including Acanthocephala spp.
[2] and Toxoplasma gondii [3], that influence host behavior to
increase their transmission efficiency. For years, scientists have
been intrigued by the association between T. gondii infection and
altered aversive behavior. The underlying mechanism(s) respon-
sible for this behavior change are presently unknown. The aim
of our study was to identify a possible explanation for this
phenomenon.
T. gondii is a common, global protozoan parasite, which requires
both a definitive host and an intermediate host to complete its life
cycle. Although felines are the only definitive host of T. gondii, any
warm-blooded animal, including humans, can be infected [4]. It is
estimated that one quarter of the population (over 12 years of age)
in the United States is positive for T. gondii infection (Center for
Disease Control, USA, 2008). Prevalence in some areas can be as
high as 95% in older populations. Latent, chronic infection, which
is characterized by parasite encystment in the host muscle and
brain cells (particularly neurons and glial cells), persists following
the resolution of acute infection and continues with seropositivity
throughout the host’s lifetime [4]. Due to its high prevalence in the
human population, it is critical to better understand the effects of
T. gondii infection in the brain.
During the chronic stage of infection, infected rodents, which
are a key intermediate host for T. gondii, exhibit a distinct
repertoire of specific behavioral changes, including a loss of
aversion to cat odors [3,5]. Infected rodents are, conversely,
attracted to these odors, and this may be responsible for increased
predation and for an increase in successful transmission of the
parasite to the feline host; as cats are the only animal that can shed
the environmentally-resistant stage of the parasite known as
oocysts. This behavior change in infected rodents during the
chronic stage of infection appears highly specific to feline odor, as
a similar change is not evoked by other predators and has no effect
on conditioned fear and anxiety [6,7]. The underlying mecha-
nism(s) responsible for this behavior change still remain unclear,
however, it has been revealed that anti-psychotic (haloperidol) and
mood-stabilizing medication (valproic acid) can prevent the
development of these behavior changes [7] in addition the
dopamine uptake inhibitor GBR12909 modifies behavioral
responses associated with latent toxoplasmosis in infected rodents
[8]. Furthermore, we have recently identified an enzyme with
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whose expression is induced during differentiation to tissue cyst
stages [9]. Several studies have suggested that T. gondii infection in
humans can have serious neurological effects [10]. Associations
have been identified between T. gondii seroprevalence and
schizophrenia [11–13]. The schizophrenia-associated risk factors
of T. gondii infection have been found to be greater than the risk
factors associated with an individual’s genes and with other
environmental factors [13,14]. Schizophrenia affects approximate-
ly 1% of the adult population and in most cases is a lifelong disease
with exacerbations. Although schizophrenia is a multifactorial
disease, pharmacological and genetic evidence suggest that
dysregulation of dopamine metabolism is involved in schizophre-
nia [15,16].
Thus, it is crucial to examine whether dopamine metabolism is
affected by T. gondii infection, particularly based on evidence of a
tyrosine hydroxylase encoded by T. gondii. To address these
questions, dopamine metabolism was monitored in vivo in the
brains of chronically infected mammals and monitored in vitro
during infection of neural cells.
Methods
Ethics statement
All animal work was performed according to national and
international guidelines following approved animal procedures by
the Beltsville Area Animal Care Committee, United States
Department of Agriculture (Protocol no. 09-010–Toxoplasmosis
in mice; approved June 4, 2009). This protocol is reviewed
annually, and any amendments are approved separately.
Growth of parasites and host cells
T. gondii strains were maintained in human foreskin fibroblasts
(HFFs) as previously described [9]. PC-12 cells obtained from
ECACC (Salisbury) were maintained as described by the supplier.
Mouse strains
Female Swiss Webster mice infected with T. gondii VEG strain
were used for histology.
Immunofluorescence assay of brain sections
Immunofluorescence against multiple targets was performed on
paraformaldehyde-fixed, paraffin-embedded mouse brain sections.
Female Swiss Webster mice were infected with T. gondii VEG
strain oocysts 6–8 weeks prior to processing. Tissues were
collected, formalin-fixed and paraffin-embedded using standard
protocols and following approved guidelines. Slides were depar-
affinized and rehydrated with an alcohol descending row, which
was then followed by epitope retrieval in 10 mM sodium citrate
buffer (pH 6.0) overnight at 60uC following sectioning. Slides were
blocked with 2% normal goat sera for 1 h at room temperature.
TRITC-conjugated lectin from Dolichos biflorus (Cat # L9658,
Sigma, St. Louis) was introduced to the slides for 4 h at room
temperature, diluted 1:200 in primary staining solution (1% BSA,
0.1% cold fish skin gelatine, 0.5% Triton X-100 in 0.1 M PBS
pH 7.2). Next, samples were washed (3610 min) in wash buffer
(TBS pH 8.4 with 0.1% Triton X-100 and 1% fish skin gelatin)
and blocked using a biotin-streptavidin blocking kit (Cat # SP-
2002, Vector Labs, Peterborough) according to the manufacturer’s
protocol. Samples were incubated with primary antibody (raised in
rabbit) against dopamine (Cat # ab8888, Abcam, Cambridge,
MA) (diluted 1:200) or tyrosine hydroxylase (Cat # ab112,
Abcam) (diluted 1:500) overnight at 4uC. Samples were rinsed with
wash buffer and incubated for 1 h with biotinylated anti-rabbit
IgG secondary antibody (Cat # B-1000, Vector Labs) diluted
1:500 in secondary antibody solution (0.05% Tween in 0.1 M PBS
pH 7.2). Sections were rinsed and incubated with FITC-
conjugated streptavidin (Cat # SA-5001, Vector Labs) diluted
1:100 according to the manufacturer’s guidelines in secondary
antibody buffer at room temperature. Finally, slides were rinsed in
wash buffer containing DAPI and double-distilled water prior to
mounting in Fluoromount G (Southern Biotech, Birmingham). All
incubation and blocking steps were carried out in a wet chamber.
All slides were kept at 4uC in the dark before imaging using a Zeiss
LSM510 META laser scanning inverted AxioVert 200M confocal
microscope with DIC optics. 3D reconstructions of serial sections
were generated with the same equipment using the LSM imaging
software for the 3D deconvolution. To assess the specificity of
dopamine staining, sections were incubated either without primary
antibody or with primary anti-dopamine antibody in the presence
of freshly prepared dopamine or serotonin for 30 min prior to and
for overnight following addition to the sections.
A T. gondii tyrosine hydroxylase antibody custom antibody
(Genscript, Piscataway) was developed to assess the parasite
enzyme in animals. The affinity purified antibody is directed
against a unique sequence (CIRSSPDPLDLRKMT) in the amino
terminal domain that is not found in mammalian tyrosine
hydroxylase and has no significant similarity to any protein in
the predicted mammalian proteome or other proteins of the T.
gondii proteome. The specificity of the antibody for T. gondii
tyrosine hydroxylase was confirmed by Western analysis. Total
protein from half mouse brains was isolated in 20 volumes (wt/
vol)lysis buffer (20 mM Tris-HCl pH 8; 137 mM NaCl; 10%
glycerol; 1% Triton X; 2 mM EDTA and protease inhibitors
(cOmplete Mini EDTA-free cocktail, Roche)) and quantified using
Bradford reagent (Sigma) as per manufacturer’s instructions.
Expression and purification of T. gondii tyrosine hydroxylase was as
previously described [9]. SDS-PAGE was following standard
protocols with 2–20 mg protein separated on a 12% sodium
dodecylsulphate- polyacrylamide gel. The proteins were trans-
ferred to nitrocellulose membrane, blocked with 5% non-fat dried
milk in PBS containing 0.05% Tween-20 (vol/vol) for 1 hour.
Incubation with the custom antibody (1:2500) 4uC overnight was
followed by washing in PBS-Tween (0.05%) and incubation with
an anti-rabbit (1:5000) conjugated horseradish peroxidase anti-
body (Sigma) at room temperature for 1 hour. Blots were then
washed as above and developed using Supersignal West Pico
Chemiluminescent kit (Pierce, Rockford, IL). Bands were
visualised with an X-Omat film system. The membrane was
stripped and re-probed with mouse anti-b-actin (1:25,000; Sigma)
overnight at 4uC followed by anti-mouse (1:10,000) conjugated
horseradish peroxidase antibody (AutogenBioclear, Wiltshire, UK)
at room temperature for 1 hour and subsequent visualisation. The
anti-T. gondii tyrosine hydroxylase antibody was used for
immunofluorescence (diluted 1:500) following a similar protocol
as described above.
Immunofluorescence of tyrosine hydroxylase in cultured
parasites was performed with paraformaldehyde-fixed cell cul-
tures. Cultures of T. gondii stably expressing RFP-conjugated
GRASP protein (kindly donated by Manami Nishi from David
Roos laboratory, University of Philadelphia, USA) in human
foreskin fibroblasts grown on polylysine-coated coverslips were
alkaline induced for differentiation as published and differentiation
monitored by counting the number of parasites in the vacuoles in
the normal and pH shifted cultures. These conditions yielded
bradyzoite forms as shown by RT-qPCR with the bradyzoite
markers BAG1 and SAG4 [9]. After five days, coverslips were
paraformaldehyde-fixed and probed with tyrosine hydroxylase
Toxoplasma and Dopamine
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as described above.
Immunohistochemical assay of brain sections
For immunohistochemical assays, sections were treated as
described above, except for the following steps: for washing and
dilution buffers, 0.1 M PBS supplemented with 0.1% Tween was
used. After antigen retrieval, slides were incubated in 0.3% H2O2
(in 0.1 M PBS) to quench endogen peroxidases. Following
secondary antibody treatment, 5 mg/ml HRP-conjugated strepta-
vidin (Cat # SA-5004, Vector Labs) was applied, and next, the
peroxidase substrate kit (Vector Labs, ImmPACT
TMDAB, Cat #
SK-4105) was used according to the manufacture’s protocol. Prior
to mounting, sections were stained with haematoxylin to visualize
cell nuclei. Imaging of slides was performed using a Zeiss Axioplan
microscope equipped with DIC optics. Photomicrographs were
collected with a Photometrics CoolSNAP camera and Improvision
Openlab software.
Glyoxylic acid staining
A cytochemical method was used to assess the dopamine
staining of tissue cyst-containing neural cells in infected mice
brain. Glyoxylic acid reacts with catecholamines in a gaseous
reaction to form fluorescent products. Dopamine reacts with
glyoxylic acid to form a product that specifically emits at 478–
480 nm [17].
Dopamine accumulation and release from dopaminergic
cells
The dopaminergic cell line PC12 (ECACC) was infected with
Prugniard strain of T. gondii tachyzoites that had been alkaline
shocked to induce bradyzoite differentiation. Liberated tachyzoites
were incubated in RPMI media at pH 8 with 1% FCS at 37uC
and ambient CO2 for 16–18 h, then rinsed with DMEM and
returned to standard PC12 cell culturing conditions. PC12 cultures
were infected 2.5610
5–7.5610
5 parasites and cultured for five
days prior to assay. The cultures infected with higher numbers of
parasites had parasitemia of 40–50%. Prior to assay, samples were
normalized to equivalent numbers of cells (2.5610
6) per assay.
One set of cultures was harvested by centrifugation and lysed by
sonication in 0.1 M perchlorate for total dopamine measurement
by HPLC with electrochemical detection. A parallel set of cultures
were equilibrated with wash buffer with low KCl containing buffer
(140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2,
11 mM dextrose, 10 mM HEPES, pH 7.4) for 30 min followed by
incubation with two volumes high KCl containing buffer (40 mM
NaCl, 100 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2,1 1m M
dextrose, 10 mM HEPES, pH 7.4) for 2 min to induce dopamine
release as previously described [18]. During the assay, samples
were taken from the media, washing buffer, and high KCl
containing buffer and immediately supplemented with 0.3 volumes
0.1 M perchlorate. Three independent experiments were per-
formed with a representative experiment shown.
Following centrifugation, cell homogenates and media were
assayed by HPLC-ED. Reverse phase chromatography, combined
with electrochemical detection, was performed with a Dionex
HPLC system consisting of a P580 Pump (Dionex) and Ultimate
3000 Autosampler Column Compartment with a C18 Acclaim
120 column (5 mm, 4.66150 mm) and an ESA Coulochem III
cell, equipped with a glassy carbon electrode used at 700 mV
versus Ag/AgCl reference electrode for detection of monoamines.
The mobile phase consisted of degassed 57 mM anhydrous citric
acid (Fisher Scientific, Loughborough), 43 mM sodium acetate
(Dionex, Sunnyvale) buffer containing 0.1 mM EDTA (Sigma
Aldrich), 1 mM sodium octanesulphonate monohydrate, and 10%
methanol. The pH was adjusted to 4. The mobile phase was
delivered at a flow rate of 1.5 ml/min, and the column
temperature was set at 40uC. Applied standards (dopamine, L-
DOPA) were dissolved in 0.1 M perchlorate for chromatography.
The concentration of compounds was determined using Chrome-
leon software.
Results
Dopamine metabolism in infected neural cells in brain
tissue
A previous study found that the global content of dopamine in
the brains of mice chronically infected with T. gondii was increased
by 14% (114% of uninfected (P,0.01)), whereas other neuro-
transmitters were unchanged [19]. The localized effects of T. gondii
infection on dopamine metabolism in tissue cysts have not been
examined. T. gondii forms intracellular tissue cysts in neurons with
each tissue cyst containing hundreds of bradyzoites (slowly
dividing stage) that may remain in situ through the host’s lifetime
[4]. Formaldehyde-fixed brain sections from mice chronically
infected with T. gondii were probed with dopamine antibody
(Abcam). Dopamine antibody staining was readily apparent in
infected cells (Fig. 1). Surprisingly, the localization was primarily
within the T. gondii tissue cysts containing the parasites visualized
as intensely stained cysts (Figs. 1, 2), rather than the host neural
cell. The dopamine antibody staining in tissue cysts was punctate.
Image rotation illuminated staining throughout the tissue cyst with
most concentrated staining near the periphery. The antibody was
raised against dopamine glutaraldehyde conjugated to bovine
serum albumin (BSA). The antibody also labelled neurons in the
amygdala and hippocampus in uninfected and infected mice (data
not shown); areas with a high concentration of dopaminergic
neurons. Intracellular tissue cysts were identified based on
morphology (for immunohistochemistry) and by labeling the
periphery of the tissue cysts with fluorescently-tagged lectin (for
immunofluorescence) [20]. DAPI counterstaining of nuclei
visualized individual parasites in the tissue cysts, highlighting the
hundreds of bradyzoites within each tissue cyst.
The presence of dopamine in tissue cyst-containing neural cells
was confirmed by cytochemical staining and competition assays.
Glyoxylic acid staining, a classic method for detection of
dopamine-containing cells by chemical reaction of glyoxylic acid
with dopamine to produce a fluorescent product [17], was applied.
Interestingly, the tissue cyst infected cells fluoresced blue and
white, with the entire cell body of the infected cell displaying
fluorescent staining (Fig. 2A). Staining of the encysted parasites
within cells and neural cell nuclei are black due to the presence of
parasite and host nuclear chromatin. The lack of cytosolic staining
in the immunofluorescent images with dopamine antibody are
likely to be due to saturation of the image with the very intense cyst
staining. The specificity of the dopamine antibody was confirmed
by competition assays. Primary dopamine antibody staining of
tissue sections was performed in the presence of exogenous
dopamine followed by secondary staining with fluorescein labelled
antibody. This eliminated staining as visualized by loss of
fluorescence (Fig. 2B). In contrast, addition of exogenous serotonin
(another catecholamine neurotransmitter) did not disrupt staining
with the dopamine antibody. This verifies that the dopamine
antibody is detecting dopamine. It remains possible that the
dopamine antibody is also detecting the metabolic precursor to
dopamine, L-DOPA, although manufacturer (Abcam) tests show a
.400-fold higher affinity for dopamine compared to L-DOPA
Toxoplasma and Dopamine
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decrease in staining with exogenous L-DOPA although this was
not quantifiable (data not shown).
T. gondii infected cells release high amounts of
dopamine
To assess whether the dopamine detected in T. gondii tissue cysts
could affect neurotransmission, the effect of T. gondii infection on
dopamine release from dopaminergic neural cells in vitro was
determined. PC12 cells were utilized as this cell line is the most
commonly used in vitro model of dopaminergic neurons.
Dopaminergic PC12 cells were infected with T. gondii parasites
incubated under conditions that induce differentiation, and
dopamine content and release were monitored by HPLC-ED.
Conditions were used (as described in the Materials and Methods)
for stage conversion of tachyzoites (the rapidly dividing stage of T.
gondii) into the tissue cyst stages (ie. bradyzoites) with alkaline pH
and decreased CO2 content as described by others [4].
The total dopamine in infected PC12 cultures was measured to
determine whether infection increases the amount of dopamine
synthesized in dopaminergic cells. Cultures were infected with
different numbers of alkaline-induced T. gondii and total dopamine
was quantitated by HPLC-ED following washes with low KCl
buffer. We found that infected cultures accumulated significantly
greater levels of dopamine and the increase correlated with
infection rate (Fig. 3). Infection led to greater than three-fold
increase in total dopamine content compared to mock-treated,
uninfected cells.
Dopamine release assays were performed with cultures of T.
gondii-infected PC12 cells to assess effects of infection on dopamine
signalling. The cultures infected with different numbers of
alkaline-induced T. gondii were induced to release dopamine with
potassium as K+ causes release of dopamine in vesicles following
methods in other studies [18]. As a result of infection, dopamine
release increased in infected cultures in a dose-dependent manner
with the number of parasites in the culture correlating with the
Figure 1. Dopamine in tissue cysts of T. gondii in brain tissue sections. (A) Dopamine was detected in brain tissue sections of chronically
infected Swiss Webster mice by immunohistochemical staining with anti-dopamine antibody and horseradish peroxidase. Tissue cysts containing
hundreds of bradyzoites are visible as brown circular structures (arrowheads) in infected brains. The bottom right panel is a control lacking anti-
dopamine antibody. All black bars are 10 mm long. (B) Localization by indirect immunofluorescence of brain sections stained with anti-dopamine
antibody (green), DAPI (blue), and TRITC-lectin (red). Three sections are shown from different regions of the brain in the top, middle and bottom rows
of panels with the negative control (no primary antibody) in the bottom row. In each series all three channels are illuminated (left), the anti-dopamine
and lectin channels are illuminated (center), and only the anti-dopamine channel is illuminated (right). The DAPI identifies neural cells and the
individual bradyzoites within the tissue cyst and the lectin stains the surface of the cyst. The dopamine staining appeared specific (also see Fig. 2) as
the antibody stained neurons in the striatum, amygdala and hippocampus. (C) A 3D projection of a Z-stack reconstruction of serial images of a tissue
cyst within a brain section stained with anti-dopamine antibody and lectin as described in B. Control without the primary anti-dopamine antibody is
shown in the right panel.
doi:10.1371/journal.pone.0023866.g001
Figure 2. Specificity of dopamine staining T. gondii tissue cysts. (A) Histochemical (glyoxylic acid) staining of dopamine in brain sections from
chronically-infected mice detected by fluorescence. Glyoxylate reacts with dopamine to fluoresce blue-white [17]. Cells containing T. gondii cysts in
brain tissue exhibited blue-white fluorescence. The tissue cysts stained darkly, similar to mouse cell nuclei, presumably due the high density of
bradyzoites. (B) Brain tissue sections from chronically-infected mice were stained with indirect fluorescein staining as in Fig. 1 except the anti-
dopamine primary antibody was incubated in the presence of 50 mg/ml dopamine (top) and 50 mg/ml serotonin (botto). From left to right: bright
field, fluorescein only channel (green), fluorescein and lectin-TRITC (green and red channels, respectively), and both channels plus bright field.
Serotonin did not compete for dopamine staining.
doi:10.1371/journal.pone.0023866.g002
Toxoplasma and Dopamine
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infected cells was up to 350% greater compared to dopamine
release in uninfected cells. Dopamine release was specific for high
KCl induction since wash buffer (Fig. 3B) and media alone (data
not shown) did not induce the release of detectable amounts of
dopamine in infected or uninfected cultures. The low KCl wash
ensures that the dopamine released is induced by potassium and
not due to dopamine released by cell lysis of infected cells. The
dopamine release reported here is the minimum amount increased
by T. gondii infection as less than or equal to half of the cells in the
cultures were infected. Normalizing for the infection rate results in
a seven-fold increase in dopamine release in infected cells relative
to uninfected PC12 cells.
Taken together, an increase in dopamine content and an
increase in dopamine release were observed in neural cells as a
direct response to T. gondii infection. The enhanced dopamine
release observed in infected cells in this study is likely to be an
underestimate of the effect on dopamine release in vivo, cultured
parasites contain few bradyzoites per vacuole compared to brain
tissue cysts that contain hundreds of bradyzoites.
Tyrosine hydroxylase is expressed in bradyzoites
Tyrosine hydroxylase is the rate-limiting enzyme in dopamine
biosynthesis. Tyrosine hydroxylase localization in the brain
sections of mice chronically infected with T. gondii was determined
to examine the expression of this crucial enzyme in infected neural
cells. Significant levels of tyrosine hydroxylase were localized within
T. gondii tissue cysts in the brain sections of infected mice (Fig. 4).
As expected, tyrosine hydroxylase was also found in the cytosol of
neurons in the expected areas of the brain in both infected and
uninfected mice (data not shown). Staining was not apparent in
control sections that were treated with only secondary antibody. It
is intriguing that both tyrosine hydroxylase and dopamine staining
were localized in the tissue cysts of infected mouse brains,
displaying similar staining patterns (Figs. 1, 4). Thus, the rate
limiting enzyme for dopamine synthesis and the product itself were
both found in T. gondii tissue cysts in the brain.
It is possible that the tyrosine hydroxylase expression observed
within the tissue cyst could be either the T. gondii-encoded tyrosine
hydroxylase or neuronal tyrosine hydroxylase that has been
imported from the host. T. gondii has complex interactions with its
host cell and co-ops several host proteins (e.g. calpains), and hence
could potentially import neuronal tyrosine hydroxylase into the
tissue cyst [21].
Alternatively, T. gondii could provide an enzyme with tyrosine
hydroxylase activity. We previously described a T. gondii encoded
tyrosine hydroxylase that could be expressed in the brain tissue
cysts [9]. T. gondii has two copies of the tyrosine hydroxylase gene
encoding nearly identical proteins (97.5%) with one gene induced
in bradyzoite-stage parasites. The parasite tyrosine hydroxylase
has a high degree of homology (53% identity) with mammalian
tyrosine hydroxylases. Unique for tyrosine hydroxylases, the
parasite orthologue enzyme contains a putative signal sequence
that could permit the enzyme to be trafficked to an organelle or
secreted by T. gondii. Additionally, it was observed that the
commercial tyrosine hydroxylase antibody used in these studies
recognizes the T. gondii encoded orthologue, as well as the
mammalian tyrosine hydroxylases (unpublished observations).
Indeed, in vitro cultivated parasites under alkaline conditions that
induce formation of bradyzoites bind commercial tyrosine
hydroxylase antibody (Fig. 4B). The tyrosine hydroxylase antibody
stains the parasitophorous vacuole and also stains the periphery of
parasites.
To specifically identify parasite-encoded tyrosine hydroxylase
within brain tissue, a custom antibody for T. gondii tyrosine
hydroxylase (TgTH) was developed. The target sequence of this
custom antibody is located in the amino-terminal domain of
TgTH, which is unique and divergent from mammalian tyrosine
hydroxylases. T. gondii tyrosine hydroxylase was localized within
tissue cysts in neural cells in chronically-infected mouse brains
(Fig. 5A). Staining was only detectable in tissue cysts in infected
neurons. Western analysis was performed to validate the specificity
of the TgTH antibody. The antibody recognized recombinant
TgTH but did not bind mouse brain proteins, confirming the
Figure 3. Elevated dopamine from T. gondii infected dopaminergic cells. (A) Overlay of HPLC-ED chromatograms derived from PC12 cells DA
release assay, where cells were infected with increasing numbers of induced tachyzoites. PC12 cells are the classic dopaminergic neuron model since
they contain all the machinery for dopamine synthesis, packaging and release. Equivalent numbers of cells were infected with T. gondii (brown,
7.5610
5; yellow, 5610
5; blue, 2.5610
5; and black, control) and incubated for 5 days followed by assaying DA release in high K+buffer. Increased
dopamine was released from infected cultures. The amount of dopamine released is correlated with number of parasites in the culture. The
experiment was repeated several times (n=4) with a representative experiment shown. (B) Graph of dopamine released from the K+ induced cultures
(squares) described in A. The total dopamine measured in each of the cultures is shown (circles). The dopamine measured in the low KCl wash buffer
for each culture is also plotted (triangles).
doi:10.1371/journal.pone.0023866.g003
Toxoplasma and Dopamine
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(Fig. 5B). Hence the intense dopamine antibody staining and
TgTH are both found in T. gondii brain tissue cysts.
Discussion
Changes in behavior of the intermediate host that could lead to
increased transmission of a parasite to its definitive host are likely
to be positively selected as these changes would provide a
significant benefit in completion of the parasite’s life cycle. T.
gondii induces behavioral alterations in infected rodents that would
facilitate the transmission of the parasite to its definitive feline host,
however, the mechanism responsible for these changes remains
unclear. Our study provides a mechanism for these changes.
Previous studies showing that anti-dopaminergic drugs can
prevent the development of the behavior changes in rodents
suggest that dopamine regulation altered by T. gondii infection of
mammals [7].
The altered behavior may be a direct effect or an indirect effect
of T. gondii infection. In this study, significant levels of dopamine
was detected by immunohistochemistry in T. gondii tissue cysts in
the brain (Fig. 1), as well as, increased dopamine release from
dopaminergic cells infected with T. gondii (Fig. 3). Based on these
novel findings, this is the first study to suggest that a parasite can
directly alter dopamine signalling to mediate host behavior
changes. These results provide a potential mechanism for T.
gondii-induced host behavioural changes.
In our study, localizing the changes in dopamine metabolism
during infection was crucial, as the location of dopamine
metabolic changes in the brain is likely to be a critical factor for
its effect on host behavior. Encysted T. gondii have been observed
in functional neurons with intact synapses [22,23]. Tissue cysts
have been detected throughout the brain, although higher
percentages of cysts were reported in the amygdala and nucleus
accumbens [5,24]. These limbic brain regions are well known to
contain dopamine that plays important functions in the control of
movements (basal ganglia), reward to stimuli, pleasure, dependen-
cy (nucleus accumbens and hippocampus), motivation and
cognition, and species and stimuli specific fear (amygdala). Altered
dopamine levels induced by T. gondii in tissue cysts in these regions
of the brain could have significant harmful consequences on a
variety of brain functions, possibly leading to an array of
behavioral changes and possible neurological malfunctions.
The observed intense dopamine staining within the T. gondii
tissue cysts in brains was unexpected. Dopamine in neurons is
synthesized in the cytosol, packaged into vesicles, and transported
along axons [25]. Thus, dopamine staining in neurons is primarily
detected within vesicles. Indeed, cytosolic dopamine can induce
cell apoptosis if it is not properly packaged into vesicles [26].
Packaged dopamine in neurons is rapidly transported away from
the cell body to the axon terminal. In our brain sections, any
dopamine released from the cyst into the cell body of the neuron
would be packaged and transported by the efficient dopaminergic
vesicle transport along axons. This may explain the apparent
lower level of dopamine in the host cell body compared to the
tissue cyst (Figs. 1, 2). Alternatively, the observed staining by the
dopamine antibody could be due to detection of L-DOPA within
the T. gondii tissue cyst that escapes the cyst and is metabolised into
dopamine in the host cytosol. This interpretation is coherent with
the observed cytosolic staining of infected neurons using glycoxylic
acid that yields a specific product with dopamine (Fig. 2). The
parasite provides tyrosine hydroxylase, the rate-limiting enzyme in
dopamine synthesis but the source of DOPA decarboxylase
required for conversion of L-DOPA to dopamine needs further
investigation. DOPA decarboxylase present in the cytosol of
dopaminergic neurons could provide this enzyme. A hypothetical
nutrient pore expressed in the parasitophorous vacuole membrane
of T. gondii tachyzoites that permits the passage of metabolites
(,1300 Da) from the host cell cytosol into the parasitophorous
vacuole could allow passage of small compounds from the vacuole
into the host cytosol [27]. If the pore is expressed in bradyzoites
then it could provide a means for dopaminergic metabolites (L-
DOPA, dopamine) to exit the vacuole and enter the host cytosol
where L-DOPA would be converted to dopamine by cytosolic
DOPA decarboxylase and dopamine would be packaged into
secretory vesicles. The generation of T. gondii mutants that will
provide a conclusive dissection of the role of the parasite’s tyrosine
hydroxylase in the dopamine synthesis and release are in progress,
but with either site of dopa decarboxylase action, the increased
dopamine metabolism has important implications on the host
neurochemistry.
In addition to dopamine, neurotransmitters such as serotonin
and glutamate need to be considered in T. gondii-induced
behavioral changes. Prior studies have proposed that the host
immune response to T. gondii infection may lead to altered neuro-
transmitter levels [28]. Immunocompetent hosts control chronic
T. gondii infection with a T-lymphocyte–driven defense [29].
Figure 4. Dopamine enzyme tyrosine hydroxylase in intracel-
lular T. gondii. (A) Immunohistochemical localization of tyrosine
hydroxylase (TH) in brain sections of chronically-infected mice with
commercial antibody and horseradish peroxidase labelling. Tissue cysts
are visible as brown circular structures (left, four cysts, and right, single
cyst, highlighted with arrowheads). (B) TH in intracellular parasites in
vitro. Alkaline-induce parasite cultures were probed with anti-tyrosine
hydroxylase antibody (green), RFP-GRASP (red), and DAPI (blue) shown
separately and as a composite image. Scale bars on all images are
10 mM.
doi:10.1371/journal.pone.0023866.g004
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involving interferon-gamma (IFN-c), interleukin-12 (IL-12), IL-18,
and tumor necrosis factor alpha (TNF-a). TNF-a induction has a
serious impact on T. gondii induced pathology at early stages of
infection. Th2-associated cytokines, such as IL-4 and IL-10,
appear relatively late after infection and may limit immune
pathology. To resolve acute infection, IFN-c induces indoleamine
2,3-dioxygenase (IDO) release, resulting in tryptophan degrada-
tion and kynurenic acid accumulation [30]. Tryptophan depletion
is thought to be responsible for suppression of the growth of the
acute stage tachyzoites. Changes in serotonin levels were not
observed in mice with T. gondii chronic infections although there
may be localized undetected changes [19]. Kynurenic acid
accumulation in the CNS could potentially alter dopamine
metabolism due to its NMDA antagonistic properties [12]. Thus,
the host immune response to T. gondii infection could contribute to
alterations in neurotransmitter levels that could affect behaviour in
conjunction with the increased dopamine mediated by the parasite.
Further studies are essential to investigate these possibilities.
Behavioral changes associated with T. gondii infection may
contribute to serious neurological disorders in humans. Several
studies have observed an association between T. gondii seroprev-
alence with schizophrenia [10,13]. Since T. gondii infection has
been found to last throughout the lifetime of the host,
seroprevalence is likely to reflect chronic infection [4]. Dopamine
dysregulation is proposed to play a central role in schizophrenia,
potentially in combination with glutamate metabolism. How
dopamine dysregulation plays a role in schizophrenia, however, is
still unknown. The principal antipsychotic drug that has been used
to treat schizophrenia, dopamine antagonist haloperidol, can also
block the development of behavior changes in T. gondii infected
rodents. It is possible that the increased dopamine accumulation
and release observed during T. gondii infection may contribute to
T. gondii associated schizophrenia. Dopamine metabolite concen-
trations have been inversely correlated with gray matter volume in
schizophrenia patients, and recent MRI evidence found that the
majority of volume reduction is in those patients seropositive for T.
gondii, suggesting that T. gondii infection leads to an increase in
dopamine metabolite concentrations [31,32]. It would be of
interest to analyze the ability of other pathogens associated with
schizophrenia, and other neurological disorders, to directly alter
dopamine metabolism to see if other pathogens have this ability or
if this phenomena is unique to T. gondii.
Malfunctions of dopamine metabolism have a serious impact on
human behavior. Dopamine dysfunction has been associated with
a variety of neurological disorders including schizophrenia,
attention deficit hyperactivity disorder, tic disorders, Tourette’s
syndrome, and dyskinesias. The novel findings of this study, that
demonstrate T. gondii’s ability to directly alter dopamine levels will
not only help to better understand the relationship between
schizophrenia and T. gondii seroprevalence, but these findings may
be critical for understanding the mechanism(s) involved in a
variety of pathogen-associated neurological disorders [10,13].
Thus, it is crucial to determine if other pathogens associated with
neurological disorders also have the ability to directly alter
dopamine levels. It is also critical to determine the possible
contributions of T. gondii infection to other dopamine-related
diseases [33,34].
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Figure 5. Expression of a parasite-encoded tyrosine hydroxylase in brain tissue cysts. (A) 3D projections of serial images of T. gondii tissue
cysts within brain sections were triple stained with T. gondii encoded tyrosine hydroxylase (TgTH) antibody (green), DAPI (blue), and lectin (red). The
panels (from left to right) show all three channels, the lectin and antibody, and TgTH antibody alone (green). Staining was not apparent in control
sections that received only secondary antibody (data not shown). DAPI identified neuronal cells and the individual bradyzoites within the tissue cyst
and lectin stained the surface of the cyst. (B) Western analysis for specificity of the custom antibody for TgTH. Recombinant protein from
D29TgAaaH2 [9] and mouse brain were probed with TgTH antibody. No bands were detected in uninfected mouse brain. b-actin was used as a
loading control.
doi:10.1371/journal.pone.0023866.g005
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